Creo Medical
UK-based Creo, founded in 2003, innovatively develops and commercialises medical devices.
Founded
2003UK-based Creo, founded in 2003, innovatively develops and commercialises medical devices.
Founded in 2003 and based in Chepstow, South Wales, Creo Medical is a pioneering medical device manufacturer. Originally known as MicroOncology Ltd, the company focuses on developing, manufacturing, and commercializing clinically innovative medical device technologies. Creo's core mission is to enhance patient outcomes through advanced medical solutions, with a vision to lead in the field of minimally invasive surgical devices. Their product portfolio includes advanced energy platforms for surgical endoscopy, targeting a global market of healthcare providers and patients.
Notable figures affiliated with Creo Medical include its experienced leadership team and a board comprising seasoned professionals from the medical and technology sectors. The company has attracted significant investment from prominent venture capital firms and strategic partners. Key achievements include regulatory approvals for their flagship products and successful clinical trials demonstrating improved patient outcomes. Creo Medical's impact is evident in its contribution to advancing minimally invasive surgery, reducing recovery times, and enhancing the overall efficiency of medical procedures worldwide.
Companies similar to Creo Medical include Cremedical, Medicreations, Proa Medical and Cambridge Endoscopic Devices.
Creo Medical was founded in 2003.
Creo Medical's headquarters is located in Chepstow, Gwent, GB.
Creo Medical's most recent funding round was for £28.5M (GBP) in February 2023.
As of Feb 17, 2023, Creo Medical has disclosed funding of $114M (USD). Undisclosed round amounts are excluded.
Creo Medical has 77 employees as of Feb 4, 2024.
Cambridge Endoscopic Devices
